How NGS-Based Testing Can Advance Reproductive Health Research
Kathy Davy, MBA
High throughput, reliability, sensitivity, and accuracy make NGS a robust reproductive health tool
laboratory testing
Response: FDA Proposes Rule to Ensure Safety and Effectiveness of LDTs
Kathryn Golab, MLS(ASCP)CM
The proposed change in LDT regulation may not be as straightforward as it seems
Rightsizing System Instrumentation: How Centralized and Decentralized Testing Models Can Improve Operations
Tyler Radke, MLS(ASCP)CM
While consolidation has led to more centralized testing, rightsizing can strike a balance by reducing waste and offering complementary services
Can Ion Mobility-MS Tackle the PFAS Testing Challenge?
Tiffany Payne, MS
Ion mobility with mass spectrometry could quickly and reliably analyze large sample volumes for PFAS
Ensuring Specimen Integrity Is Everyone’s Job
Emily Berlin, BS, MBA
Delivering high-quality patient care heavily relies on eliminating medical errors and maintaining specimen integrity
FDA Proposes Rule to Ensure Safety and Effectiveness of LDTs
U.S. Food and Drug Administration
New rule could address the exponentially rising risks associated with most modern LDTs
NIH to Address Unmet At-Home, PoC Testing Tech Needs
National Institute of Biomedical Imaging and Bioengineering
POCTRN to apply COVID-19 experience and expertise to develop testing, monitoring, and treating technologies
How to Implement Accessible On-Demand Testing
Christina P. Nickel, MHA, MLS(ASCP)CM, CPHQ
On-demand testing doesn’t require registration, billing, or scheduling, keeping costs low while collecting “real” dollars upfront
Easing Regulatory Concerns about Linearity Testing in Clinical Chemistry Labs
Robert J. Janetschek, MS, MT(ASCP)
Clarity and consistency in defining terms may help laboratorians better adhere to industry guidelines
Taking the “Forever” Out of PFAS Forever Chemicals
Tiffany Payne, MS
Are we at a turning point for regulations related to PFAS compounds?